APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Urine and Oral Fluid Drug Tests

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Urine and Oral Fluid Drug Tests Market Outlook and Growth Opportunities 2026

Report ID 173925440427 December 2025206 pages

Choose your research edition.

Industry ResearchUrine and Oral Fluid Drug Tests Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Urine and Oral Fluid Drug Tests Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Urine and Oral Fluid Drug Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urine and Oral Fluid Drug Tests Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Urine and Oral Fluid Drug Tests Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Urine and Oral Fluid Drug Tests market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Urine and Oral Fluid Drug Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Urine and Oral Fluid Drug Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urine and Oral Fluid Drug Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Urine and Oral Fluid Drug Tests market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Urine and Oral Fluid Drug Tests market include 77 Elektronika Kft., Arkray, Beckman Coulter, Inova Diagnostics, Quest Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Aicon Biotechnology Co., Ltd. and Aiwei Technology Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Urine and Oral Fluid Drug Tests market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Urine and Oral Fluid Drug Tests and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Urine and Oral Fluid Drug Tests sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Urine and Oral Fluid Drug Tests market size, projected growth trends, production technologies, key applications, and end-use industries.

Urine and Oral Fluid Drug Tests Segment by Company

77 Elektronika Kft.

Arkray

Beckman Coulter

Inova Diagnostics

Quest Diagnostics

Siemens Healthineers

Thermo Fisher Scientific

Aicon Biotechnology Co., Ltd.

Aiwei Technology Co., Ltd.

Beijing Kuer Technology Co., Ltd.

Beijing Manor Biopharmaceutical Co., Ltd.

Beijing Wantai Biopharmaceutical Co., Ltd.

Chengdu Union Biotechnology Co., Ltd.

Decheng Biotechnology Co., Ltd.

Guangzhou Wanfu Biological Technology Co., Ltd.

Roche

Wancheng Biotechnology Co., Ltd.

Abbott

Urine and Oral Fluid Drug Tests Segment by Type

Oral Fluid Test

Urine Test

Urine and Oral Fluid Drug Tests Segment by Application

Toxicology Testing

Forensic Evidence Collection

Personal Use

Urine and Oral Fluid Drug Tests Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Urine and Oral Fluid Drug Tests status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Urine and Oral Fluid Drug Tests market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Urine and Oral Fluid Drug Tests significant trends, drivers, influence factors in global and regions.

6. To analyze Urine and Oral Fluid Drug Tests competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urine and Oral Fluid Drug Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urine and Oral Fluid Drug Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urine and Oral Fluid Drug Tests.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Urine and Oral Fluid Drug Tests market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Urine and Oral Fluid Drug Tests industry.

Chapter 3: Detailed analysis of Urine and Oral Fluid Drug Tests manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Urine and Oral Fluid Drug Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Urine and Oral Fluid Drug Tests in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Urine and Oral Fluid Drug Tests Industry Trends Table 2. Urine and Oral Fluid Drug Tests Industry Drivers Table 3. Urine and Oral Fluid Drug Tests Industry Opportunities and Challenges Table 4. Urine and Oral Fluid Drug Tests Industry Restraints Table 5. Global Urine and Oral Fluid Drug Tests Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Urine and Oral Fluid Drug Tests Revenue Share by Company (2021-2026) Table 7. Global Urine and Oral Fluid Drug Tests Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Urine and Oral Fluid Drug Tests Sales Volume Share by Company (2021-2026) Table 9. Global Urine and Oral Fluid Drug Tests Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Urine and Oral Fluid Drug Tests Company Ranking, (2024-2026) & (USD Million) Table 11. Global Urine and Oral Fluid Drug Tests Key Company Manufacturing Base & Headquarters Table 12. Global Urine and Oral Fluid Drug Tests Company, Product Type & Application Table 13. Global Urine and Oral Fluid Drug Tests Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Urine and Oral Fluid Drug Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Fluid Test Table 18. Significant Companies of Urine Test Table 19. Global Urine and Oral Fluid Drug Tests Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Urine and Oral Fluid Drug Tests Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Urine and Oral Fluid Drug Tests Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Urine and Oral Fluid Drug Tests Sales Volume Share by Type (2021-2026) Table 23. Global Urine and Oral Fluid Drug Tests Sales Volume Share by Type (2027-2032) Table 24. Global Urine and Oral Fluid Drug Tests Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Urine and Oral Fluid Drug Tests Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Urine and Oral Fluid Drug Tests Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Urine and Oral Fluid Drug Tests Sales Value Share by Type (2021-2026) Table 28. Global Urine and Oral Fluid Drug Tests Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Toxicology Testing Table 30. Significant Companies of Forensic Evidence Collection Table 31. Significant Companies of Personal Use Table 32. Global Urine and Oral Fluid Drug Tests Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Urine and Oral Fluid Drug Tests Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Urine and Oral Fluid Drug Tests Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Urine and Oral Fluid Drug Tests Sales Volume Share by Application (2021-2026) Table 36. Global Urine and Oral Fluid Drug Tests Sales Volume Share by Application (2027-2032) Table 37. Global Urine and Oral Fluid Drug Tests Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Urine and Oral Fluid Drug Tests Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Urine and Oral Fluid Drug Tests Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Urine and Oral Fluid Drug Tests Sales Value Share by Application (2021-2026) Table 41. Global Urine and Oral Fluid Drug Tests Sales Value Share by Application (2027-2032) Table 42. Global Urine and Oral Fluid Drug Tests Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Urine and Oral Fluid Drug Tests Sales by Region (2021-2026) & (K Units) Table 44. Global Urine and Oral Fluid Drug Tests Sales Market Share by Region (2021-2026) Table 45. Global Urine and Oral Fluid Drug Tests Sales by Region (2027-2032) & (K Units) Table 46. Global Urine and Oral Fluid Drug Tests Sales Market Share by Region (2027-2032) Table 47. Global Urine and Oral Fluid Drug Tests Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Urine and Oral Fluid Drug Tests Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Urine and Oral Fluid Drug Tests Sales Value Share by Region (2021-2026) Table 50. Global Urine and Oral Fluid Drug Tests Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Urine and Oral Fluid Drug Tests Sales Value Share by Region (2027-2032) Table 52. Global Urine and Oral Fluid Drug Tests Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Urine and Oral Fluid Drug Tests Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Urine and Oral Fluid Drug Tests Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Urine and Oral Fluid Drug Tests Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Urine and Oral Fluid Drug Tests Sales by Country (2021-2026) & (K Units) Table 57. Global Urine and Oral Fluid Drug Tests Sales Market Share by Country (2021-2026) Table 58. Global Urine and Oral Fluid Drug Tests Sales by Country (2027-2032) & (K Units) Table 59. Global Urine and Oral Fluid Drug Tests Sales Market Share by Country (2027-2032) Table 60. Global Urine and Oral Fluid Drug Tests Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Urine and Oral Fluid Drug Tests Sales Value Market Share by Country (2021-2026) Table 62. Global Urine and Oral Fluid Drug Tests Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Urine and Oral Fluid Drug Tests Sales Value Market Share by Country (2027-2032) Table 64. 77 Elektronika Kft. Company Information Table 65. 77 Elektronika Kft. Business Overview Table 66. 77 Elektronika Kft. Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. 77 Elektronika Kft. Urine and Oral Fluid Drug Tests Product Portfolio Table 68. 77 Elektronika Kft. Recent Development Table 69. Arkray Company Information Table 70. Arkray Business Overview Table 71. Arkray Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Arkray Urine and Oral Fluid Drug Tests Product Portfolio Table 73. Arkray Recent Development Table 74. Beckman Coulter Company Information Table 75. Beckman Coulter Business Overview Table 76. Beckman Coulter Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Beckman Coulter Urine and Oral Fluid Drug Tests Product Portfolio Table 78. Beckman Coulter Recent Development Table 79. Inova Diagnostics Company Information Table 80. Inova Diagnostics Business Overview Table 81. Inova Diagnostics Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Inova Diagnostics Urine and Oral Fluid Drug Tests Product Portfolio Table 83. Inova Diagnostics Recent Development Table 84. Quest Diagnostics Company Information Table 85. Quest Diagnostics Business Overview Table 86. Quest Diagnostics Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Quest Diagnostics Urine and Oral Fluid Drug Tests Product Portfolio Table 88. Quest Diagnostics Recent Development Table 89. Siemens Healthineers Company Information Table 90. Siemens Healthineers Business Overview Table 91. Siemens Healthineers Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Siemens Healthineers Urine and Oral Fluid Drug Tests Product Portfolio Table 93. Siemens Healthineers Recent Development Table 94. Thermo Fisher Scientific Company Information Table 95. Thermo Fisher Scientific Business Overview Table 96. Thermo Fisher Scientific Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Thermo Fisher Scientific Urine and Oral Fluid Drug Tests Product Portfolio Table 98. Thermo Fisher Scientific Recent Development Table 99. Aicon Biotechnology Co., Ltd. Company Information Table 100. Aicon Biotechnology Co., Ltd. Business Overview Table 101. Aicon Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Aicon Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 103. Aicon Biotechnology Co., Ltd. Recent Development Table 104. Aiwei Technology Co., Ltd. Company Information Table 105. Aiwei Technology Co., Ltd. Business Overview Table 106. Aiwei Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Aiwei Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 108. Aiwei Technology Co., Ltd. Recent Development Table 109. Beijing Kuer Technology Co., Ltd. Company Information Table 110. Beijing Kuer Technology Co., Ltd. Business Overview Table 111. Beijing Kuer Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Beijing Kuer Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 113. Beijing Kuer Technology Co., Ltd. Recent Development Table 114. Beijing Manor Biopharmaceutical Co., Ltd. Company Information Table 115. Beijing Manor Biopharmaceutical Co., Ltd. Business Overview Table 116. Beijing Manor Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Beijing Manor Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 118. Beijing Manor Biopharmaceutical Co., Ltd. Recent Development Table 119. Beijing Wantai Biopharmaceutical Co., Ltd. Company Information Table 120. Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview Table 121. Beijing Wantai Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Beijing Wantai Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 123. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Development Table 124. Chengdu Union Biotechnology Co., Ltd. Company Information Table 125. Chengdu Union Biotechnology Co., Ltd. Business Overview Table 126. Chengdu Union Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Chengdu Union Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 128. Chengdu Union Biotechnology Co., Ltd. Recent Development Table 129. Decheng Biotechnology Co., Ltd. Company Information Table 130. Decheng Biotechnology Co., Ltd. Business Overview Table 131. Decheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Decheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 133. Decheng Biotechnology Co., Ltd. Recent Development Table 134. Guangzhou Wanfu Biological Technology Co., Ltd. Company Information Table 135. Guangzhou Wanfu Biological Technology Co., Ltd. Business Overview Table 136. Guangzhou Wanfu Biological Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Guangzhou Wanfu Biological Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 138. Guangzhou Wanfu Biological Technology Co., Ltd. Recent Development Table 139. Roche Company Information Table 140. Roche Business Overview Table 141. Roche Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Roche Urine and Oral Fluid Drug Tests Product Portfolio Table 143. Roche Recent Development Table 144. Wancheng Biotechnology Co., Ltd. Company Information Table 145. Wancheng Biotechnology Co., Ltd. Business Overview Table 146. Wancheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Wancheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 148. Wancheng Biotechnology Co., Ltd. Recent Development Table 149. Abbott Company Information Table 150. Abbott Business Overview Table 151. Abbott Urine and Oral Fluid Drug Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Abbott Urine and Oral Fluid Drug Tests Product Portfolio Table 153. Abbott Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Urine and Oral Fluid Drug Tests Distributors List Table 157. Urine and Oral Fluid Drug Tests Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Urine and Oral Fluid Drug Tests Product Image Figure 2. Global Urine and Oral Fluid Drug Tests Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urine and Oral Fluid Drug Tests Sales Value (2021-2032) & (US$ Million) Figure 4. Global Urine and Oral Fluid Drug Tests Sales (2021-2032) & (K Units) Figure 5. Global Urine and Oral Fluid Drug Tests Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Urine and Oral Fluid Drug Tests Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Fluid Test Image Figure 10. Urine Test Image Figure 11. Global Urine and Oral Fluid Drug Tests Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Urine and Oral Fluid Drug Tests Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Urine and Oral Fluid Drug Tests Sales Volume Share by Type (2021-2032) Figure 14. Global Urine and Oral Fluid Drug Tests Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Urine and Oral Fluid Drug Tests Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Urine and Oral Fluid Drug Tests Sales Value Share by Type (2021-2032) Figure 17. Toxicology Testing Image Figure 18. Forensic Evidence Collection Image Figure 19. Personal Use Image Figure 20. Global Urine and Oral Fluid Drug Tests Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Urine and Oral Fluid Drug Tests Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Urine and Oral Fluid Drug Tests Sales Volume Share by Application (2021-2032) Figure 23. Global Urine and Oral Fluid Drug Tests Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Urine and Oral Fluid Drug Tests Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Urine and Oral Fluid Drug Tests Sales Value Share by Application (2021-2032) Figure 26. Global Urine and Oral Fluid Drug Tests Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Urine and Oral Fluid Drug Tests Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Urine and Oral Fluid Drug Tests Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Urine and Oral Fluid Drug Tests Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Urine and Oral Fluid Drug Tests Sales Value (2021-2032) & (US$ Million) Figure 31. North America Urine and Oral Fluid Drug Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Urine and Oral Fluid Drug Tests Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Urine and Oral Fluid Drug Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Urine and Oral Fluid Drug Tests Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Urine and Oral Fluid Drug Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Urine and Oral Fluid Drug Tests Sales Value (2021-2032) & (US$ Million) Figure 37. South America Urine and Oral Fluid Drug Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Urine and Oral Fluid Drug Tests Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Urine and Oral Fluid Drug Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Urine and Oral Fluid Drug Tests Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Urine and Oral Fluid Drug Tests Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Fluid Test
  • Urine Test
Applications
  • Toxicology Testing
  • Forensic Evidence Collection
  • Personal Use
Companies covered
  • 77 Elektronika Kft.
  • Arkray
  • Beckman Coulter
  • Inova Diagnostics
  • Quest Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Aicon Biotechnology Co., Ltd.
  • Aiwei Technology Co., Ltd.
  • Beijing Kuer Technology Co., Ltd.
  • Beijing Manor Biopharmaceutical Co., Ltd.
  • Beijing Wantai Biopharmaceutical Co., Ltd.
  • Chengdu Union Biotechnology Co., Ltd.
  • Decheng Biotechnology Co., Ltd.
  • Guangzhou Wanfu Biological Technology Co., Ltd.
  • Roche
  • Wancheng Biotechnology Co., Ltd.
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Urine and Oral Fluid Drug Tests Sales Value (2021-2032)
  4. 1.2.2 Global Urine and Oral Fluid Drug Tests Sales Volume (2021-2032)
  5. 1.2.3 Global Urine and Oral Fluid Drug Tests Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Urine and Oral Fluid Drug Tests Market Dynamics
  1. 2.1 Urine and Oral Fluid Drug Tests Industry Trends
  2. 2.2 Urine and Oral Fluid Drug Tests Industry Drivers
  3. 2.3 Urine and Oral Fluid Drug Tests Industry Opportunities and Challenges
  4. 2.4 Urine and Oral Fluid Drug Tests Industry Restraints
3 Urine and Oral Fluid Drug Tests Market by Company
  1. 3.1 Global Urine and Oral Fluid Drug Tests Company Revenue Ranking in 2025
  2. 3.2 Global Urine and Oral Fluid Drug Tests Revenue by Company (2021-2026)
  3. 3.3 Global Urine and Oral Fluid Drug Tests Sales Volume by Company (2021-2026)
  4. 3.4 Global Urine and Oral Fluid Drug Tests Average Price by Company (2021-2026)
  5. 3.5 Global Urine and Oral Fluid Drug Tests Company Ranking (2024-2026)
  6. 3.6 Global Urine and Oral Fluid Drug Tests Company Manufacturing Base and Headquarters
  7. 3.7 Global Urine and Oral Fluid Drug Tests Company Product Type and Application
  8. 3.8 Global Urine and Oral Fluid Drug Tests Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Urine and Oral Fluid Drug Tests Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Urine and Oral Fluid Drug Tests Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Urine and Oral Fluid Drug Tests Market by Type
  1. 4.1 Urine and Oral Fluid Drug Tests Type Introduction
  2. 4.1.1 Oral Fluid Test
  3. 4.1.2 Urine Test
  4. 4.2 Global Urine and Oral Fluid Drug Tests Sales Volume by Type
  5. 4.2.1 Global Urine and Oral Fluid Drug Tests Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Urine and Oral Fluid Drug Tests Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Urine and Oral Fluid Drug Tests Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Urine and Oral Fluid Drug Tests Sales Value by Type
  9. 4.3.1 Global Urine and Oral Fluid Drug Tests Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Urine and Oral Fluid Drug Tests Sales Value by Type (2021-2032)
  11. 4.3.3 Global Urine and Oral Fluid Drug Tests Sales Value Share by Type (2021-2032)
5 Urine and Oral Fluid Drug Tests Market by Application
  1. 5.1 Urine and Oral Fluid Drug Tests Application Introduction
  2. 5.1.1 Toxicology Testing
  3. 5.1.2 Forensic Evidence Collection
  4. 5.1.3 Personal Use
  5. 5.2 Global Urine and Oral Fluid Drug Tests Sales Volume by Application
  6. 5.2.1 Global Urine and Oral Fluid Drug Tests Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Urine and Oral Fluid Drug Tests Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Urine and Oral Fluid Drug Tests Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Urine and Oral Fluid Drug Tests Sales Value by Application
  10. 5.3.1 Global Urine and Oral Fluid Drug Tests Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Urine and Oral Fluid Drug Tests Sales Value by Application (2021-2032)
  12. 5.3.3 Global Urine and Oral Fluid Drug Tests Sales Value Share by Application (2021-2032)
6 Urine and Oral Fluid Drug Tests Regional Sales and Value Analysis
  1. 6.1 Global Urine and Oral Fluid Drug Tests Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Urine and Oral Fluid Drug Tests Sales by Region (2021-2032)
  3. 6.2.1 Global Urine and Oral Fluid Drug Tests Sales by Region: 2021-2026
  4. 6.2.2 Global Urine and Oral Fluid Drug Tests Sales by Region (2027-2032)
  5. 6.3 Global Urine and Oral Fluid Drug Tests Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Urine and Oral Fluid Drug Tests Sales Value by Region (2021-2032)
  7. 6.4.1 Global Urine and Oral Fluid Drug Tests Sales Value by Region: 2021-2026
  8. 6.4.2 Global Urine and Oral Fluid Drug Tests Sales Value by Region (2027-2032)
  9. 6.5 Global Urine and Oral Fluid Drug Tests Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Urine and Oral Fluid Drug Tests Sales Value (2021-2032)
  12. 6.6.2 North America Urine and Oral Fluid Drug Tests Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Urine and Oral Fluid Drug Tests Sales Value (2021-2032)
  15. 6.7.2 Europe Urine and Oral Fluid Drug Tests Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Urine and Oral Fluid Drug Tests Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Urine and Oral Fluid Drug Tests Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Urine and Oral Fluid Drug Tests Sales Value (2021-2032)
  21. 6.9.2 South America Urine and Oral Fluid Drug Tests Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Urine and Oral Fluid Drug Tests Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Urine and Oral Fluid Drug Tests Sales Value Share by Country, 2025 VS 2032
7 Urine and Oral Fluid Drug Tests Country-level Sales and Value Analysis
  1. 7.1 Global Urine and Oral Fluid Drug Tests Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Urine and Oral Fluid Drug Tests Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Urine and Oral Fluid Drug Tests Sales by Country (2021-2032)
  4. 7.3.1 Global Urine and Oral Fluid Drug Tests Sales by Country (2021-2026)
  5. 7.3.2 Global Urine and Oral Fluid Drug Tests Sales by Country (2027-2032)
  6. 7.4 Global Urine and Oral Fluid Drug Tests Sales Value by Country (2021-2032)
  7. 7.4.1 Global Urine and Oral Fluid Drug Tests Sales Value by Country (2021-2026)
  8. 7.4.2 Global Urine and Oral Fluid Drug Tests Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Urine and Oral Fluid Drug Tests Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Urine and Oral Fluid Drug Tests Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Urine and Oral Fluid Drug Tests Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 77 Elektronika Kft.
  2. 8.1.1 77 Elektronika Kft. Company Information
  3. 8.1.2 77 Elektronika Kft. Business Overview
  4. 8.1.3 77 Elektronika Kft. Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 77 Elektronika Kft. Urine and Oral Fluid Drug Tests Product Portfolio
  6. 8.1.5 77 Elektronika Kft. Recent Developments
  7. 8.2 Arkray
  8. 8.2.1 Arkray Company Information
  9. 8.2.2 Arkray Business Overview
  10. 8.2.3 Arkray Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Arkray Urine and Oral Fluid Drug Tests Product Portfolio
  12. 8.2.5 Arkray Recent Developments
  13. 8.3 Beckman Coulter
  14. 8.3.1 Beckman Coulter Company Information
  15. 8.3.2 Beckman Coulter Business Overview
  16. 8.3.3 Beckman Coulter Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Beckman Coulter Urine and Oral Fluid Drug Tests Product Portfolio
  18. 8.3.5 Beckman Coulter Recent Developments
  19. 8.4 Inova Diagnostics
  20. 8.4.1 Inova Diagnostics Company Information
  21. 8.4.2 Inova Diagnostics Business Overview
  22. 8.4.3 Inova Diagnostics Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Inova Diagnostics Urine and Oral Fluid Drug Tests Product Portfolio
  24. 8.4.5 Inova Diagnostics Recent Developments
  25. 8.5 Quest Diagnostics
  26. 8.5.1 Quest Diagnostics Company Information
  27. 8.5.2 Quest Diagnostics Business Overview
  28. 8.5.3 Quest Diagnostics Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Quest Diagnostics Urine and Oral Fluid Drug Tests Product Portfolio
  30. 8.5.5 Quest Diagnostics Recent Developments
  31. 8.6 Siemens Healthineers
  32. 8.6.1 Siemens Healthineers Company Information
  33. 8.6.2 Siemens Healthineers Business Overview
  34. 8.6.3 Siemens Healthineers Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Siemens Healthineers Urine and Oral Fluid Drug Tests Product Portfolio
  36. 8.6.5 Siemens Healthineers Recent Developments
  37. 8.7 Thermo Fisher Scientific
  38. 8.7.1 Thermo Fisher Scientific Company Information
  39. 8.7.2 Thermo Fisher Scientific Business Overview
  40. 8.7.3 Thermo Fisher Scientific Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Thermo Fisher Scientific Urine and Oral Fluid Drug Tests Product Portfolio
  42. 8.7.5 Thermo Fisher Scientific Recent Developments
  43. 8.8 Aicon Biotechnology Co., Ltd.
  44. 8.8.1 Aicon Biotechnology Co., Ltd. Company Information
  45. 8.8.2 Aicon Biotechnology Co., Ltd. Business Overview
  46. 8.8.3 Aicon Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Aicon Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  48. 8.8.5 Aicon Biotechnology Co., Ltd. Recent Developments
  49. 8.9 Aiwei Technology Co., Ltd.
  50. 8.9.1 Aiwei Technology Co., Ltd. Company Information
  51. 8.9.2 Aiwei Technology Co., Ltd. Business Overview
  52. 8.9.3 Aiwei Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Aiwei Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  54. 8.9.5 Aiwei Technology Co., Ltd. Recent Developments
  55. 8.10 Beijing Kuer Technology Co., Ltd.
  56. 8.10.1 Beijing Kuer Technology Co., Ltd. Company Information
  57. 8.10.2 Beijing Kuer Technology Co., Ltd. Business Overview
  58. 8.10.3 Beijing Kuer Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Kuer Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  60. 8.10.5 Beijing Kuer Technology Co., Ltd. Recent Developments
  61. 8.11 Beijing Manor Biopharmaceutical Co., Ltd.
  62. 8.11.1 Beijing Manor Biopharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Beijing Manor Biopharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Beijing Manor Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Manor Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  66. 8.11.5 Beijing Manor Biopharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Beijing Wantai Biopharmaceutical Co., Ltd.
  68. 8.12.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Beijing Wantai Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Beijing Wantai Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  72. 8.12.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Chengdu Union Biotechnology Co., Ltd.
  74. 8.13.1 Chengdu Union Biotechnology Co., Ltd. Company Information
  75. 8.13.2 Chengdu Union Biotechnology Co., Ltd. Business Overview
  76. 8.13.3 Chengdu Union Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Chengdu Union Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  78. 8.13.5 Chengdu Union Biotechnology Co., Ltd. Recent Developments
  79. 8.14 Decheng Biotechnology Co., Ltd.
  80. 8.14.1 Decheng Biotechnology Co., Ltd. Company Information
  81. 8.14.2 Decheng Biotechnology Co., Ltd. Business Overview
  82. 8.14.3 Decheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Decheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  84. 8.14.5 Decheng Biotechnology Co., Ltd. Recent Developments
  85. 8.15 Guangzhou Wanfu Biological Technology Co., Ltd.
  86. 8.15.1 Guangzhou Wanfu Biological Technology Co., Ltd. Company Information
  87. 8.15.2 Guangzhou Wanfu Biological Technology Co., Ltd. Business Overview
  88. 8.15.3 Guangzhou Wanfu Biological Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Guangzhou Wanfu Biological Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  90. 8.15.5 Guangzhou Wanfu Biological Technology Co., Ltd. Recent Developments
  91. 8.16 Roche
  92. 8.16.1 Roche Company Information
  93. 8.16.2 Roche Business Overview
  94. 8.16.3 Roche Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Roche Urine and Oral Fluid Drug Tests Product Portfolio
  96. 8.16.5 Roche Recent Developments
  97. 8.17 Wancheng Biotechnology Co., Ltd.
  98. 8.17.1 Wancheng Biotechnology Co., Ltd. Company Information
  99. 8.17.2 Wancheng Biotechnology Co., Ltd. Business Overview
  100. 8.17.3 Wancheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Wancheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  102. 8.17.5 Wancheng Biotechnology Co., Ltd. Recent Developments
  103. 8.18 Abbott
  104. 8.18.1 Abbott Company Information
  105. 8.18.2 Abbott Business Overview
  106. 8.18.3 Abbott Urine and Oral Fluid Drug Tests Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Abbott Urine and Oral Fluid Drug Tests Product Portfolio
  108. 8.18.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Urine and Oral Fluid Drug Tests Value Chain Analysis
  2. 9.1.1 Urine and Oral Fluid Drug Tests Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Urine and Oral Fluid Drug Tests Sales Mode & Process
  6. 9.2 Urine and Oral Fluid Drug Tests Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Urine and Oral Fluid Drug Tests Distributors
  9. 9.2.3 Urine and Oral Fluid Drug Tests Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst